Advocacy intelligence hub — real-time data for patient organizations
Rinri Therapeutics — PHASE1, PHASE2
Akouos, Inc.
Akouos, Inc. — PHASE1, PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Michio Hirano, MD, M.D
Columbia University
📍 NEW YORK, NY
Nathalie LOUNDON, MD
Assistance Publique - Hôpitaux de Paris
Peter Marks, MD, MD
Eli Lilly and Company
📍 GRAND RAPIDS, MI
Anne Chiaramello, Ph.D.
George Washington University School of Medicine and Health Sciences
Debra Regier, M.D., Ph.D., MD
Children's National Hospital; Children's National Rare Disease Institute
📍 WASHINGTON, DC